Labs2Life among the top performers in the 2025 Osservatorio sul Merito
26 June 2025
/
Specialized in designing and managing research labs, Labs2Life has been recognized as one of Italy’s most outstanding companies in 2025.
Labs2Life, a startup incubated and affiliated with Bio4Dreams, has been selected as one of the featured companies in the 2025 edition of Osservatorio sul Merito, an editorial initiative that annually highlights Italy’s most outstanding organizations for innovation, impact, and strategic vision.
Founded in 2020 and developed in close synergy with Bio4Dreams, Labs2Life has established itself as a leading player in the integrated design and management of research laboratories, offering customized spaces and specialized services for startups, research centers, universities, and companies.
“We come from the world of laboratories. We speak the language of researchers. We’re able to bring researchers’ ideas to life while meeting the standards of traditional engineering.”
Claudio Gattuso, CEO and Co-founder of Labs2Life
Osservatorio sul Merito is an annual initiative that showcases Italian SMEs that combine excellence, resilience, and social value in their respective sectors.
The article was published in a special insert of Corriere della Sera and in Panorama.
Congratulations to the entire Labs2Life team on this important recognition, which confirms the value of their contribution to innovation in the Life Sciences.
Last updates
24 Apr 26
A stronger clinical and regulatory pathway with RIDE2Med Foundation
A new partnership with RIDE2Med Foundation to provide startups with advanced regulatory expertise and access to a qualified clinical network.
23 Apr 26
NERD project kicks off, a cross-border initiative for precision oncology
The NERD kick-off meeting was held in Como for the Interreg Italy–Switzerland project led by Bio4Dreams to advance innovation in precision oncology
9 Apr 26
Immersive virtual reality for fibromyalgia wins the Mattia Crosetto Award
The project using virtual reality to support fibromyalgia treatment wins the award named after Mattia Crosetto.